# Trade Mark Journal No.2025/051 19 December 2025

## UK00004306052 5 December 2025 (5,35,39,40,42)

AGILERA

Class 5
  Radiopharmaceutical and radioisotope preparations for clinical, medical, diagnostic and therapeutic use.
Class 35
  Regulatory submission management services, namely, assisting others in preparing and filing applications for radiopharmaceuticals with governmental regulatory bodies; distributorship services in the field of radiopharmaceuticals; distributorship services featuring pharmaceuticals, radiopharmaceuticals, and nuclear medicine products; business management and logistics management in the field of radiopharmaceuticals; supply chain management for pharmaceutical and radiopharmaceutical products; business administration and consulting services for radiopharmaceutical and radiopharmacy operations.
Class 39
  Supply chain and logistics services, namely, transportation, delivery, distribution, and storage of radiopharmaceuticals and radioisotopes; consultation and coordination services relating to the transport and storage of radiopharmaceuticals and radioisotopes.
Class 40
  Manufacturing services in the field of pharmaceuticals and radiopharmaceuticals; isotope production for medical, research, and commercial use; contract development and manufacturing services (CDMO) in the field of pharmaceuticals and radiopharmaceuticals; Custom manufacture of pharmaceuticals; Contract manufacturing in the field of pharmaceuticals; fill and finishing services, namely, clinical manufacturing of drug formulations for others to support clinical trials.
Class 42
  Scientific and technological services and research in the field of radiochemistry, radiopharmaceuticals, and nuclear medicine; laboratory testing, quality control, and validation services for radiopharmaceuticals; process development, optimization, and scale-up services; technological consultancy relating to radiopharmaceutical production and regulatory compliance; design and development of computer software for radiopharmacy workflow management, data analysis, and quality assurance; Pharmaceutical drug development services; Laboratory services for the production of radiopharmaceuticals in the nature of research and development of new products and testing of pharmaceuticals; Quality control for others.

Agilera Pharma AS

Representative: Edwin Coe LLP